BreStem Therapeutics
Raleigh, US · Founded 2017
Biotech
Founders & leadership
DZ
Dongmei ZhuExecutive Officer
KC
Ke ChengExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$3MraisedNov 2021 · 3 investors · Other Health Care
Rule 506(b)$50KraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.